PHARMACOKINETICS AND EXPOSURE-RESPONSE OF TOFACITINIB IN A PHASE 3 MAINTENANCE STUDY IN ULCERATIVE COLITIS PATIENTS

被引：2
|
作者：
Mukherjee, Arnab
D'Haens, Geert R.
Sandborn, William J.
Tsuchiwata, Shinichi
Vong, Camille
Deng, Chenhui
Xie, Rujia
Hazra, Anasuya
Martin, Steven W.
Friedman, Gary
Niezychowski, Wojciech
Su, Chinyu
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)32133-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1917
引用
收藏
页码：S595 / S596
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics and exposure-response of tofacitinib in a Phase 3 maintenance study in ulcerative colitis patients
    Mukherjee, A.
    D'Haens, G. R.
    Sandborn, W. J.
    Tsuchiwata, S.
    Vong, C.
    Deng, C.
    Xie, R.
    Hazra, A.
    Martin, S. W.
    Friedman, G.
    Niezychowski, W.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S69 - S70
  • [2] A Markov Transition Model for Characterization of Exposure-Response of Tofacitinib During Maintenance Therapy in Patients with Ulcerative Colitis
    Tsuchiwata, Shinichi
    Suzuki, Akiyuki
    Mukherjee, Arnab
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S9 - S9
  • [3] Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
    Ana Victoria Ponce-Bobadilla
    Sven Stodtmann
    Doerthe Eckert
    Wen Zhou
    Wei Liu
    Mohamed-Eslam F. Mohamed
    Clinical Pharmacokinetics, 2023, 62 : 101 - 112
  • [4] Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
    Ponce-Bobadilla, Ana Victoria
    Stodtmann, Sven
    Eckert, Doerthe
    Zhou, Wen
    Liu, Wei
    Mohamed, Mohamed-Eslam F.
    CLINICAL PHARMACOKINETICS, 2023, 62 (01) : 101 - 112
  • [5] Pharmacokinetics and Exposure-Response Relationships of Ustekinumab in Patients With Ulcerative Colitis: Results From the UNIFI Induction and Maintenance Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen
    O'Brien, Christopher
    Szapary, Philippe
    Zhang, Hongyan
    Johanns, Jewel
    Leong, Rupert W. L.
    Hisamatsu, Tadakazu
    Van Assche, Gert
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S481 - S482
  • [6] Exposure-Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies
    Mukherjee, Arnab
    Tsuchiwata, Shinichi
    Nicholas, Timothy
    Cook, Jack A.
    Modesto, Irene
    Su, Chinyu
    D'Haens, Geert R.
    Sandborn, William J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 90 - 100
  • [7] MIRIKIZUMAB PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM RANDOMISED PHASE 2 AND PHASE 3 INDUCTION AND MAINTENANCE TRIALS
    Friedrich, Stuart
    Chua, Laiyi
    Zhang, Xin
    GASTROENTEROLOGY, 2023, 164 (06) : S1217 - S1218
  • [8] Mirikizumab pharmacokinetics and exposure-response relationships in patients with moderately to severely active ulcerative colitis: results from randomised phase 2 and phase 3 induction and maintenance trials
    Friedrich, S.
    Chua, L.
    Zhang, X. C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 646 - 646
  • [9] Pharmacokinetics and exposure-response analyses of upadacitinib in patients with moderate to severe ulcerative colitis - Analyses of induction and maintenance clinical trials
    Ponce-Bobadilla, A. V.
    Stodtmann, S.
    Eckert, D.
    Zhou, W.
    Liu, W.
    Mohamed, M. E.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I355 - I357
  • [10] Mirikizumab pharmacokinetics and exposure-response in pediatric patients with moderate-to-severe ulcerative colitis
    Otani, Yuki
    Chua, Laiyi
    Komocsar, Wendy J.
    Larkin, Amy
    Johns, Jordan
    Zhang, Xin
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025, 14 (03): : 474 - 485
12345